{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T15:16:35Z","timestamp":1789917395764,"version":"4.0.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T00:00:00Z","timestamp":1469750400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s00277-016-2765-0","type":"journal-article","created":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T20:05:22Z","timestamp":1469736322000},"page":"1611-1616","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Correlation between JAK2 allele burden and pulmonary arterial hypertension and hematological parameters in Philadelphia negative JAK2 positive myeloproliferative neoplasms. An Egyptian experience"],"prefix":"10.1007","volume":"95","author":[{"given":"Mervat M.","family":"Mattar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Abdel Kader","family":"Morad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha M.","family":"El Husseiny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha H.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa M.","family":"El Demerdash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,29]]},"reference":[{"key":"2765_CR1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3322\/caac.20009","volume":"59","author":"AM Vannucchi","year":"2009","unstructured":"Vannucchi AM, Guglielmelli P, Tefferi A (2009) Advances in understanding and management of myeloproliferative neoplasms. CA Cancer J Clin 59:171\u2013191","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2765_CR2","doi-asserted-by":"crossref","first-page":"e52518","DOI":"10.1371\/journal.pone.0052518","volume":"8","author":"HR Kim","year":"2013","unstructured":"Kim HR, Choi HJ, Kim YK et al (2013) Allelic expression imbalance of JAK2 V617F mutation in BCR-ABL negative myeloproliferative neoplasms. PLoS One 8(1):e52518","journal-title":"PLoS One"},{"key":"2765_CR3","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1080\/10428190701493928","volume":"48","author":"A Altintas","year":"2007","unstructured":"Altintas A, Karahan Z, Pasa S et al (2007) Pulmonary hypertension in patients with essential thrombocythemia and reactive thrombocytosis. Leuk Lymphoma 48:1981\u20131987","journal-title":"Leuk Lymphoma"},{"key":"2765_CR4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijcard.2003.08.013","volume":"97","author":"G Kadikoylu","year":"2004","unstructured":"Kadikoylu G, Onbasili A, Tekten T et al (2004) Functional and morphological cardiac changes in myeloproliferative disorders (clinical study). Int J Cardiol 97:213\u2013220","journal-title":"Int J Cardiol"},{"key":"2765_CR5","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/sj.leu.2404943","volume":"22","author":"A Cortelezzi","year":"2008","unstructured":"Cortelezzi A, Gritti G, Del Papa N et al (2008) Pulmonary arterial hypertension in primary myelofibrosis is common and associated with an altered angiogenic status. Leukemia 22:646\u2013649","journal-title":"Leukemia"},{"issue":"3","key":"2765_CR6","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.healun.2014.09.009","volume":"34","author":"EC Roach","year":"2015","unstructured":"Roach EC, Park MM, Tang WH et al (2015) Impaired right ventricular-pulmonary vascular function in myeloproliferative neoplasms. J Heart Lung Transplant 34(3):390\u2013394","journal-title":"J Heart Lung Transplant"},{"key":"2765_CR7","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1183\/09031936.00175909","volume":"35","author":"Y Adir","year":"2010","unstructured":"Adir Y, Humbert M (2010) Pulmonary hypertension in patients with chronic myeloproliferative disorders. Eur Respir J 35:1396\u20131406","journal-title":"Eur Respir J"},{"issue":"6","key":"2765_CR8","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1200\/JCO.2010.31.8436","volume":"29","author":"T Barbui","year":"2011","unstructured":"Barbui T, Barosi G, Birgegard G et al (2011) Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European leukemia Net. J Clin Oncol 29(6):761\u2013770","journal-title":"J Clin Oncol"},{"issue":"1","key":"2765_CR9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"N Gali\u00e8","year":"2016","unstructured":"Gali\u00e8 N, Humbert M, Vachiery JL et al (2016) 2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European society of cardiology (ESC) and the European respiratory society (ERS): endorsed by: association for European paediatric and congenital cardiology (AEPC), international society for heart and lung transplantation (ISHLT). Eur Heart J 37(1):67\u2013119","journal-title":"Eur Heart J"},{"key":"2765_CR10","first-page":"245","volume":"89","author":"V Garypidou","year":"2004","unstructured":"Garypidou V, Vakalopoulou S, Dimitriadis D et al (2004) Incidence of pulmonary hypertension in patients with chronic myeloproliferative disorders. Hoematologica 89:245\u2013246","journal-title":"Hoematologica"},{"issue":"8","key":"2765_CR11","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/hrt.2010.212084","volume":"97","author":"S Janda","year":"2011","unstructured":"Janda S, Shahidi N, Gin K, Swiston J (2011) Diagnostic accuracy of echocardiography for pulmonary hypertension: a systematic review and meta-analysis. Heart 97(8):612\u2013622","journal-title":"Heart"},{"key":"2765_CR12","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/0002-9343(92)90576-W","volume":"93","author":"SA Reisner","year":"1992","unstructured":"Reisner SA, Rinkevich D, Markiewicz W et al (1992) Cardiac involvement in patients with myeloproliferative disorders. Am J Med 93:498\u2013504","journal-title":"Am J Med"},{"key":"2765_CR13","first-page":"1779","volume":"98","author":"R Gupta","year":"2006","unstructured":"Gupta R, Perumandla S, Patsiornik Y et al (2006) Incidence of pulmonary hypertension in patients with chronic myeloproliferative disorders. J Natl Med Assoc 98:1779\u20131782","journal-title":"J Natl Med Assoc"},{"key":"2765_CR14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/10428194.2013.797083","volume":"55","author":"S Chebrek","year":"2014","unstructured":"Chebrek S, A\u00efssi K, Franc\u00e8s Y et al (2014) Pulmonary hypertension in patients with chronic myeloproliferative neoplasm. Leuk Lymphoma 55:223\u2013225","journal-title":"Leuk Lymphoma"},{"key":"2765_CR15","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1378\/chest.120.3.801","volume":"120","author":"D Dingli","year":"2001","unstructured":"Dingli D, Utz JP, Krowka MJ et al (2001) Unexplained pulmonary hypertension in chronic myeloproliferative disorders. Chest 120:801\u2013808","journal-title":"Chest"},{"issue":"2","key":"2765_CR16","doi-asserted-by":"crossref","first-page":"e57856","DOI":"10.1371\/journal.pone.0057856","volume":"8","author":"J Zhou","year":"2013","unstructured":"Zhou J, Ye Y, Zeng S et al (2013) Impact of JAK2 V617F mutation on hemogram variation in patients with Non-reactive elevated platelet counts. PLoS One 8(2):e57856","journal-title":"PLoS One"},{"issue":"2","key":"2765_CR17","first-page":"105","volume":"29","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, Li L, Nie L et al (2008) Clinical study on relationship between JAK2 V617F mutation and chronic myeloproliferative disorders. Zhonghua Xue Ye Xue Za Zhi 29(2):105\u2013109","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"2765_CR18","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1002\/cncr.22663","volume":"109","author":"J Kittur","year":"2007","unstructured":"Kittur J, Knudson RA, Lasho TL et al (2007) Clinical correlates of JAK2V617F allele burden in essential thrombocythemia. Cancer 109:2279\u20132284","journal-title":"Cancer"},{"issue":"6","key":"2765_CR19","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1600-0609.2007.00960.x","volume":"79","author":"TS Larsen","year":"2007","unstructured":"Larsen TS, Pallisgaard N, M\u00f8ller MB, Hasselbalch HC (2007) The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis\u2014impact on disease phenotype. Eur J Haematol 79(6):508\u2013515","journal-title":"Eur J Haematol"},{"key":"2765_CR20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.leukres.2010.06.017","volume":"35","author":"RT Silver","year":"2011","unstructured":"Silver RT, Vandris K, Wang YL et al (2011) JAK2 (V617F) allele burden in polycythemia vera correlates with grade of myelofibrosis, but is not substantially affected by therapy. Leuk Res 35:177","journal-title":"Leuk Res"},{"issue":"16","key":"2765_CR21","doi-asserted-by":"crossref","first-page":"7327","DOI":"10.7314\/APJCP.2015.16.16.7327","volume":"16","author":"S Sultan","year":"2015","unstructured":"Sultan S, Irfan SM (2015) Acquired JAK-2 V617F mutational analysis in Pakistani patients with essential thrombocythemia. Asian Pac J Cancer Prev 16(16):7327\u20137330","journal-title":"Asian Pac J Cancer Prev"},{"key":"2765_CR22","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.5858\/arpa.2013-0018-OA","volume":"138","author":"N Vytrva","year":"2014","unstructured":"Vytrva N, Stacher E, Regitnig P et al (2014) Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F. Arch Pathol Lab Med 138:1203","journal-title":"Arch Pathol Lab Med"},{"key":"2765_CR23","first-page":"859","volume":"3","author":"AN Duletic","year":"2012","unstructured":"Duletic AN, Dekanic A, Hadzisejdic I et al (2012) JAK2-V617F mutation is associated with clinical and laboratory features of myeloproliferative NeoplasmsColl. Antropol 3:859\u2013865","journal-title":"Antropol"},{"key":"2765_CR24","unstructured":"Chao HY, Fan Z, Zhang R, et al (2009) Detection and clinical significance of JAK2 mutation in 412 patients with chronic myeloproliferative neoplasms. Zhonghua Zhong Liu Za Zhi 31(7):510\u20134"},{"key":"2765_CR25","first-page":"77","volume":"2","author":"G Ilhan","year":"2012","unstructured":"Ilhan G, Karakus S, Sahin FI (2012) JAK 2V617F mutation: frequency and relation to clinical and laboratory features of BCR-ABL negative myeloproliferative diseases. Int J Hematol Oncol 2:77\u201384","journal-title":"Int J Hematol Oncol"},{"key":"2765_CR26","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1038\/sj.leu.2404755","volume":"21","author":"N Pemmaraju","year":"2007","unstructured":"Pemmaraju N, Moliterno AR, Williams DM et al (2007) The quantitative JAK2 V617F neutrophil allele burden does not correlate with thrombotic risk in essential thrombocytosis. Leukemia 21:2210\u20132212","journal-title":"Leukemia"},{"key":"2765_CR27","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1182\/blood-2007-07-099184","volume":"110","author":"G Barosi","year":"2007","unstructured":"Barosi G, Bergamaschi G, Marchetti M et al (2007) JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis. Blood 110:4030\u20134036","journal-title":"Blood"},{"issue":"9501","key":"2765_CR28","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/S0140-6736(05)67785-9","volume":"366","author":"PJ Campbell","year":"2005","unstructured":"Campbell PJ, Scott LM, Buck G et al (2005) Definition of subtypes of essential thrombocythemia and relation to polycythemia vera based on JAK2 V617F mutation status: a prospective study. Lancet 366(9501):1945\u20131953","journal-title":"Lancet"},{"issue":"suppl.2","key":"2765_CR29","first-page":"547","volume":"92","author":"C Garcia","year":"2007","unstructured":"Garcia C, de Carranza ST, Campos CB et al (2007) Correlation between LDH levels and mutational status of JAK2 gene in essential thrombocythemia. Haematologica 92(suppl2):547","journal-title":"Haematologica"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-016-2765-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-016-2765-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-016-2765-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T15:28:19Z","timestamp":1498318099000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-016-2765-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,29]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["2765"],"URL":"https:\/\/doi.org\/10.1007\/s00277-016-2765-0","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,29]]}}}